SUTENT 25 mg, gélule — 28 plaquette(s) thermoformée(s) polychlortrifluoroéthylène PVC de 1 gélule(s)

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400938210392
  • CIP7 3821039
  • CIS 65283820
  • Registration number EU/1/06/347

What the source publishes

Holder
PFIZER EUROPE MA EEIG (BELGIQUE)
Active ingredients
SUNITINIB, MALATE DE SUNITINIB
Form
gélule
Package
28 plaquette(s) thermoformée(s) polychlortrifluoroéthylène PVC de 1 gélule(s)
Routes
orale
Administrative status
authorised
Supply regime
médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; prescription réservée aux spécialistes et services HEMATOLOGIE ; prescription hospitalière ; liste I ; prescription réservée aux médecins compétents en CANCEROLOGIE
Marketing status
Déclaration de commercialisation
Authorised on
2006-07-19
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400938210392
{
  "cis": "65283820",
  "cip7": "3821039",
  "form": "gélule",
  "name": "SUTENT 25 mg, gélule — 28 plaquette(s) thermoformée(s) polychlortrifluoroéthylène PVC de 1 gélule(s)",
  "cip13": "3400938210392",
  "holder": "PFIZER EUROPE MA EEIG (BELGIQUE)",
  "routes": [
    "orale"
  ],
  "holders": [
    "PFIZER EUROPE MA EEIG (BELGIQUE)"
  ],
  "currency": "EUR",
  "marketed": true,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": "929.64",
  "authorisedOn": "2006-07-19",
  "compositions": [
    {
      "name": "SUNITINIB",
      "nature": "FT",
      "strength": "25 mg",
      "linkageNumber": "1",
      "substanceCode": "29335",
      "dosageReference": "une gélule",
      "pharmaceuticalElement": "gélule"
    },
    {
      "name": "MALATE DE SUNITINIB",
      "nature": "SA",
      "strength": null,
      "linkageNumber": "1",
      "substanceCode": "41239",
      "dosageReference": null,
      "pharmaceuticalElement": "gélule"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; prescription réservée aux spécialistes et services HEMATOLOGIE ; prescription hospitalière ; liste I ; prescription réservée aux médecins compétents en CANCEROLOGIE",
  "dispensingFee": "1.02",
  "medicinePrice": "928.62",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "SUTENT 25 mg, gélule",
  "marketingStatus": "Déclaration de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-01-08",
    "CIS_CIP_bdpm": "2026-11-19",
    "CIS_CPD_bdpm": "2026-01-08",
    "CIS_COMPO_bdpm": "2026-01-08"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "oui",
  "packageDescription": "28 plaquette(s) thermoformée(s) polychlortrifluoroéthylène PVC de 1 gélule(s)",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "100%"
  ],
  "marketingDeclaredOn": "2008-10-07",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "SUNITINIB",
    "MALATE DE SUNITINIB"
  ],
  "authorisationProcedure": "Procédure centralisée",
  "prescriptionConditions": [
    "médicament nécessitant une surveillance particulière pendant le traitement",
    "prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE",
    "prescription réservée aux spécialistes et services HEMATOLOGIE",
    "prescription hospitalière",
    "liste I",
    "prescription réservée aux médecins compétents en CANCEROLOGIE"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": "EU/1/06/347",
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400938210392"